10,075
Total Claims
$1.6M
Drug Cost
1,335
Beneficiaries
$1,202
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-21%
Cost per patient vs peers
$1,202 vs $1,524 avg
-2%
Brand preference vs peers
13.4% vs 13.7% avg
Brand vs Generic
87% generic
Brand: 1,352 claims · $1.4M
Generic: 8,723 claims · $197K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 884 | $1.0M |
| Rivaroxaban | 184 | $209K |
| Sacubitril/Valsartan | 56 | $85K |
| Evolocumab | 42 | $42K |
| Empagliflozin | 18 | $24K |
| Valsartan | 220 | $15K |
| Diltiazem Hcl | 335 | $13K |
| Metoprolol Succinate | 519 | $13K |
| Rosuvastatin Calcium | 611 | $10K |
| Atorvastatin Calcium | 596 | $9,465 |
| Potassium Chloride | 315 | $8,791 |
| Carvedilol | 751 | $8,505 |
| Flecainide Acetate | 117 | $8,283 |
| Evolocumab | 12 | $7,392 |
| Clopidogrel Bisulfate | 275 | $5,597 |
Prescribing Profile
61
Unique Drugs
$1.3M
Patient Profile
76
Avg Age
50%
Female
1.44
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data